Navigation Links
Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
Date:3/8/2011

romise from typical doses of XEOMIN.

ADVERSE REACTIONS

  • Cervical Dystonia:  The most commonly observed adverse reactions (incidence greater than or equal to 10% of patients and twice the rate of placebo) for XEOMIN 120 Units and XEOMIN 240 Units, respectively, were: dysphagia (13%, 18%), neck pain (7%, 15%), muscle weakness (7%, 11%), and musculoskeletal pain (7%, 4%).
  • Blepharospasm: The most common adverse reactions (incidence greater than or equal to 10% of patients and twice the rate of placebo) for XEOMIN were eyelid ptosis (19%), dry mouth (16%), visual impairment (12%), diarrhea (8%), and headache (7%).

  • DRUG INTERACTIONSConcomitant treatment of XEOMIN and aminoglycoside antibiotics, spectinomycin, or other agents that interfere with neuromuscular transmission (e.g., tubocurarine-like agents), or muscle relaxants, should be observed closely because the effect of XEOMIN may be potentiated.

    USE IN PREGNANCYPregnancy Category C: There are no adequate and well-controlled studies in pregnant women. XEOMIN should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

    Please see full prescribing information for XEOMIN, including Boxed WARNING, available at www.XEOMIN.com.

    About MerzMerz Pharmaceuticals, LLC is a part of the Merz Group of companies and was established in 1995 to develop and commercialize products for the Merz Group. Areas of therapeutic focus include Neurology, Dermatology, and Podiatry.

    With a 102 year heritage, the Merz Group is known worldwide for its development of original compounds and formulations for medical professionals and consumers in 90 countries. Globally, Merz is a leader in the development of pharmaceuticals for the treatment of neurological and psychological disorders as well as for aesthetic medicine. Global research is concentrated in field
    '/>"/>

    SOURCE Merz Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/18/2014)... 18, 2014  In a policy paper ... the nation,s largest lesbian, gay, bisexual and transgender ... of Truvada for Pre-Exposure Prophylaxis (PrEP). PrEP is ... prevent the spread of a disease or infection ... name anti-HIV drug combination currently approved for PrEP, ...
    (Date:10/17/2014)... NORWALK, Conn. , Oct. 17, 2014 UBM ... , a leading online community and information resource for ... Parkinson disease and Alzheimer disease , with discussions ... Up to 1 million Americans have Parkinson disease , ... muscular dystrophy, or Lou Gehrig disease. Diagnosis can ...
    (Date:10/17/2014)... Oct. 17, 2014 A victim of medical negligence ... doctor with a history of alcohol abuse, a physician ... on Prop 46 today, highlighting how Prop 46 will identify ... testing. The ad pictures a doctor drinking ... To ER."  Proposition 46 will enact the first law in ...
    Breaking Medicine Technology:HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 2HRC Endorses PrEP, Calls for Bold Action to Expand Access to Anti-HIV Drug 3Neurology Times Features Coverage of Parkinson and Alzheimer Disease 2Neurology Times Features Coverage of Parkinson and Alzheimer Disease 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4
    (Date:10/18/2014)... October 19, 2014 Mercy’s student mentoring ... report on programs that help college students succeed. ... software and services, published the recent paper, “Retention and ... and Mercy is one of six higher education institutions ... fall to fall retention rates for first-time, full-time students ...
    (Date:10/18/2014)... (PRWEB) October 19, 2014 Recently, BamboofloorChina.com, one ... market, has added a new assortment of bamboo floorings ... offering huge price cuts for worldwide clients now, up to ... of useful and durable items for sale now; most of ... decades. Clients can find more than 100 different kinds of ...
    (Date:10/18/2014)... October 2014 All humans have a natural opioid system ... ECNP Congress in Berlin, has found that the opioid ... normal healthy volunteers. The work was carried out by ... and was funded by the Medical Research Council. This ... Neuropsychopharmacology congress in Berlin., Gambling is a widespread behaviour ...
    (Date:10/18/2014)... NY (PRWEB) October 18, 2014 Ticket Down is ... prices have eased considerably for this year's World Series. ... in the World Series this year. This determined team has ... The San Francisco Giants have had better luck in terms of ... 2010, 1954, 1933, 1922, 1921 and 1905. This team ...
    (Date:10/18/2014)... 18, 2014 Market Research ... Industry, 2009-2019 is a professional and in-depth ... Chondroitin sulfate industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Chondroitin sulfate listing their product ...
    Breaking Medicine News(10 mins):Health News:Mercy’s PACT Student Mentoring Program Recognized for Helping College Students Succeed 2Health News:Brand New Bamboo Floorings Now Unveiled By BamboofloorChina.com, A Distinguished Supplier In The Market 2Health News:Pathological gambling is associated with altered opioid system in the brain: Reduced feeling of euphoria when compared to healthy volunteers 2Health News:2014 World Series Tickets: Giants vs. Royals World Series Ticket Prices Have Eased Substantially 2Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 2Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 3Health News:Chondroitin Sulfate Industry Global & Chinese Forecast to 2019 Now Available at RnRMarketResearch.com 4
    ... 22 Val J. Halamandaris,President of the National Association ... Americans to commemorate the power of caring, both at ... National Home,Care and Hospice Month., "It is highly ... day to,celebrate the nurses, therapists, aides and other providers ...
    ... 22, 2007 The Autism Consortium, a group of ... and enhancing clinical care for autism, announced today that ... Spectrum Disorders (ASD) through its Autism Gene Discovery Project ... database that autism researchers around the world can use. ...
    ... 2007Four Mary Ann Liebert, Inc. journals are participating in ... a special worldwide publishing event on October 22, 2007 ... and human development. The Council of Science Editors has ... of key journals throughout the world, including those published ...
    ... giveaway, researcher says, , , MONDAY, Oct. 22 (HealthDay News) -- ... lung doctor says a common device can determine whether someone ... could be used to ferret out people who hide a ... also help show patients what smoking is doing to their ...
    ... (Chicago, IL, October 22, 2007) A new study shows ... vary with age. The study presented at CHEST 2007, the ... Chest Physicians (ACCP), found that smokers over age 65 reported ... a major health problem, while smokers under age 65 reported ...
    ... important advances toward a therapeutic device that has the ... blood stream and treat them. Among other applications, such ... tissues, or signal stem cells to differentiate. , Their ... cells down as they flow through blood vessels. As ...
    Cached Medicine News:Health News:U.S. Celebrates National Home Care and Hospice Month in November 2Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 2Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 3Health News:Autism Consortium releases data on genes involved in autism to researchers worldwide 4Health News:Global theme issue on poverty and human development 2Health News:Blood Test Catches Secret Smokers 2Health News:Blood Test Catches Secret Smokers 3Health News:Age affects motivation for quitting smoking 2Health News:MIT works toward novel therapeutic device 2Health News:MIT works toward novel therapeutic device 3
    Digital Ultrasonic Diagnostic Imaging System...
    ...
    Pefakit PiCT DxS Diluent for Determination of Total Heparin...
    Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
    Medicine Products: